Briefings & More
Sort By: Newest first | Oldest first
There are a few developments in this year’s Budget that are of particular interest for those operating in the life sciences sector.
On 2 April 2014, the European Parliament voted in favour of the implementation of a new Clinical Trials Regulation.
Italy’s highest administrative court has ruled that Pfizer’s use of patents and SPCs relating to Xalatan/latanoprost in Italy constituted an abuse of its dominant position.
Dare to share? Proposed new directive should help protect your confidential information when doing business in Europe
The European Commission’s new directive should help businesses to stop others from obtaining, disclosing or using their trade secrets in the EU without their permission.
Lookalikes: a wealth of confusion… brand-owners vs own-branders | competition law vs law of unfair competition
Lookalikes are an age-old problem as brand-owners try to protect their brands from copying or leveraging by retailers or others.
The European Commission’s first decisions on ‘pay-for-delay’ arrangements attempt a tricky balancing of competing legal and policy objectives.